MiMedx Group (NASDAQ: MDXG) reported Q2 EPS of $0.00, $0.02 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $81.3 million versus the consensus estimate of $74.84 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.